Cited by 103

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Myeloid-Specific Rictor Deletion Induces M1 Macrophage Polarization and Potentiates In Vivo Pro-Inflammatory Response to Lipopolysaccharide

Festuccia, William T., Pouliot, Philippe, Bakan, Inan, Sabatini, David M., Laplante, Mathieu·2014·PLoS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0095432

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 14 references

Research works printed but not linked: 44

  1. S Gordon, 2003, Alternative activation of macrophages, Nat Rev Immunol, 3, 23, 10.1038/nri978 · DOI · Paper page
  2. T Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, 11, 373, 10.1038/ni.1863 · DOI · Paper page
  3. LA O’Neill, 2009, Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer, Pharmacol Rev, 61, 177, 10.1124/pr.109.001073 · DOI
  4. JM Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu Rev Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846 · DOI · Paper page
  5. JA Engelman, 2006, The Role of the ErbB Family Members in Non-Small Cell “Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors”, Clin Cancer Res, 12, 4372s, 10.1158/1078-0432.CCR-06-0795 · DOI
  6. BD Manning, 2007, AKT/PKB signaling: navigating downstream, Cell, 129, 1261, 10.1016/j.cell.2007.06.009 · DOI · Paper page
  7. J Brown, 2011, TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk, J Dent Res, 90, 417, 10.1177/0022034510381264 · DOI
  8. K Hazeki, 2007, Role of phosphoinositide 3-kinase in innate immunity, Biol Pharm Bull, 30, 1617, 10.1248/bpb.30.1617 · DOI
  9. TD Troutman, 2012, Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K, Cell Cycle, 11, 3559, 10.4161/cc.21572 · DOI
  10. TD Troutman, 2012, Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt, Proc Natl Acad Sci U S A, 109, 273, 10.1073/pnas.1118579109 · DOI
  11. L Arbibe, 2000, Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway, Nat Immunol, 1, 533, 10.1038/82797 · DOI
  12. SN Sarkar, 2004, Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling, Nat Struct Mol Biol, 11, 1060, 10.1038/nsmb847 · DOI
  13. SH Rhee, 2006, Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells, J Biol Chem, 281, 18560, 10.1074/jbc.M513861200 · DOI · Paper page
  14. M Ni, 2012, B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K, Proc Natl Acad Sci U S A, 109, 267, 10.1073/pnas.1111957108 · DOI
  15. J Brown, 2011, Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1, J Biol Chem, 286, 44295, 10.1074/jbc.M111.258053 · DOI
  16. VA McGuire, 2013, Cross Talk between the Akt and p38alpha Pathways in Macrophages Downstream of Toll-Like Receptor Signaling, Mol Cell Biol, 33, 4152, 10.1128/MCB.01691-12 · DOI
  17. M Ojaniemi, 2003, Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages, Eur J Immunol, 33, 597, 10.1002/eji.200323376 · DOI
  18. B Chaurasia, 2010, Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages, Mol Cell Biol, 30, 4354, 10.1128/MCB.00069-10 · DOI
  19. A Arranz, 2012, Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization, Proc Natl Acad Sci U S A, 109, 9517, 10.1073/pnas.1119038109 · DOI
  20. M Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017 · DOI · Paper page
  21. DA Guertin, 2006, Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1, Dev Cell, 11, 859, 10.1016/j.devcel.2006.10.007 · DOI
  22. C Shiota, 2006, Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability, Dev Cell, 11, 583, 10.1016/j.devcel.2006.08.013 · DOI
  23. BE Clausen, 1999, Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgenic Res, 8, 265, 10.1023/A:1008942828960 · DOI · Paper page
  24. DR Alessi, 1997, Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha, Curr Biol, 7, 261, 10.1016/S0960-9822(06)00122-9 · DOI
  25. JM Garcia-Martinez, 2008, mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1), Biochem J, 416, 375, 10.1042/BJ20081668 · DOI · Paper page
  26. E Jacinto, 2006, SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity, Cell, 127, 125, 10.1016/j.cell.2006.08.033 · DOI
  27. R Cancello, 2006, Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity, Diabetes, 55, 1554, 10.2337/db06-0133 · DOI · Paper page
  28. H Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 · DOI · Paper page
  29. GS Habicht, 1981, Body temperature in normal and endotoxin-treated mice of different ages, Mech Ageing Dev, 16, 97, 10.1016/0047-6374(81)90037-3 · DOI
  30. F Bauss, 1987, Tumor necrosis factor mediates endotoxic effects in mice, Infect Immun, 55, 1622, 10.1128/IAI.55.7.1622-1625.1987 · DOI
  31. M Martin, 2005, Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3, Nat Immunol, 6, 777, 10.1038/ni1221 · DOI
  32. W Fan, 2010, FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages, EMBO J, 29, 4223, 10.1038/emboj.2010.268 · DOI
  33. MF Siqueira, 2010, Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1), Diabetologia, 53, 378, 10.1007/s00125-009-1529-y · DOI
  34. D Su, 2009, FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages, Diabetes, 58, 2624, 10.2337/db09-0232 · DOI
  35. Y Kawano, 2012, Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance, Diabetes, 61, 1935, 10.2337/db11-0770 · DOI
  36. R Cancello, 2006, Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue, Bjog, 113, 1141, 10.1111/j.1471-0528.2006.01004.x · DOI · Paper page
  37. K Cusi, 2010, The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes, Curr Diab Rep, 10, 306, 10.1007/s11892-010-0122-6 · DOI
  38. SP Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
  39. GS Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
  40. V Hietakangas, 2007, Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth, Genes Dev, 21, 632, 10.1101/gad.416307 · DOI
  41. JP Luyendyk, 2008, Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages, J Immunol, 180, 4218, 10.4049/jimmunol.180.6.4218 · DOI
  42. G Schabbauer, 2004, PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice, Arterioscler Thromb Vasc Biol, 24, 1963, 10.1161/01.ATV.0000143096.15099.ce · DOI
  43. B Zou, 2012, Timing of insulin therapy affects the inflammatory response in endotoxemic rats, Inflammation, 35, 723, 10.1007/s10753-011-9367-8 · DOI
  44. MG Jeschke, 2004, Insulin attenuates the systemic inflammatory response in endotoxemic rats, Endocrinology, 145, 4084, 10.1210/en.2004-0592 · DOI

Cited by

Sorted by citations

See all 103

Metadata

Authors
Festuccia, W. T., Pouliot, P., Bakan, I., Sabatini, D. M., & Laplante, M.
Venue
PLoS ONE
Published
2014-04-16
Volume
9
Issue
4
Pages
e95432
ISSN
1932-6203
Cited by
103
References
14
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review